AroCell AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported sales was SEK 12.47 million compared to SEK 5.89 million a year ago. Net loss was SEK 16.52 million compared to SEK 19.7 million a year ago. Basic loss per share from continuing operations was SEK 0.07 compared to SEK 0.17 a year ago. Diluted loss per share from continuing operations was SEK 0.07 compared to SEK 0.17 a year ago.
For the full year, sales was SEK 36.99 million compared to SEK 12 million a year ago. Net loss was SEK 58.97 million compared to SEK 50.03 million a year ago. Basic loss per share from continuing operations was SEK 0.28.